-
Gefitinib, sold
under the
brand name Iressa, is a
medication used for
certain breast, lung and
other cancers.
Gefitinib is an EGFR inhibitor, like erlotinib...
- this case,
Gefitinib is the
inhibitor of
tyrosine kinase.
Incorrect tyrosine kinase function can lead to non-small cell lung cancer.
Gefitinib is a tyrosine...
- the U.S. Food and Drug
Administration (FDA)
approved the
quinazoline gefitinib. The drug,
produced by AstraZeneca, is an
inhibitor of the
protein kinase...
-
therapeutics directed against EGFR (called "EGFR inhibitors", EGFRi),
including gefitinib, erlotinib, afatinib,
brigatinib and
icotinib for lung cancer, and cetuximab...
- for
bronchorrhea vary
depending on the
inciting cause; they include:
gefitinib -
epidermal growth factor receptor tyrosine kinase inhibitor indomethacin...
-
Methylphenidate and dextroamphetamine-induced
peripheral vasculopathy Gefitinib Obstruction of capillaries:
Cryoglobulinaemia –
proteins in the blood...
- the
frequency and
amplitude modulated, they
applied the EGFR
inhibitor gefitinib or the
highly selective MAPK/ERK
kinase (MEK)
inhibitor PD0325901 (PD)...
-
Irinotecan Topotecan Etoposide Teniposide Tafluposide Bortezomib Erlotinib Gefitinib Imatinib Vemurafenib Vismodegib Azacitidine Azathioprine Capecitabine...
-
imatinib may be
effective in
treatment of
dermatofibrosarcoma protuberans.
Gefitinib (Iressa, also
known as ZD1839),
targets the
epidermal growth factor receptor...
- a double-blind, head-to-head
phase III
study comparing icotinib with
gefitinib in 399
patients across 27
centers in China.
Results showed icotinib to...
